Markus Enzelberger, PhD.

is a Versant Partner.

Markus is a Versant Partner located in Basel where he plays a central role in the launch of future NewCos from Versant's Ridgeline Discovery Engine.

He is a seasoned executive with deep domain knowledge of drug discovery and development, especially in the protein field. Markus most recently was CSO and a member of the management board of MorphoSys having joined in 2002. He is recognised as an authority in the field of protein engineering.


Markus holds a Ph.D. from the Technical University of Stuttgart, Germany.

Getting in touch


Ridgeline Therapeutics GmbH
A Versant Ventures Discovery Engine

Aeschenvorstadt 36

CH 4051 Basel


Offices  and Labs

Ridgeline Therapeutics GmbH
Hochbergerstrasse 60C
CH 4057 Basel

A Versant Ventures Discovery Engine.




Imprint  /  Privacy Policy  /  Terms of Use

© 2018 Ridgeline Therapeutics GmbH,
Ridgeline Discovery GmbH